Skip to content

Clinical trials

Completed Prostatic Hyperplasia trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Hyperplasia Status: Completed Country / region: United Kingdom Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20052
20061
20072
20081
20091
20103
20111
20121
20142
20151
20161
20182

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline4
Astellas Pharma Europe B.V.2
NeoTract, Inc.2
AEterna Zentaris1
Aberdeen Royal Infirmary1
Allergan1
Astellas Pharma Global Development, Inc.1
Astellas Pharma Inc1
Boston Scientific Corporation1
Cardiff and Vale University Health Board1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Hyperplasia20
Lower Urinary Tract Symptoms7
Prostatic Neoplasms2
Hypertrophy1
Neoplasms1
Sexual Dysfunction, Physiological1
Urinary Bladder, Overactive1
Urinary Incontinence1
Urinary Retention1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.